Dynavax Technologies Statistics

Total Valuation

Dynavax Technologies has a market cap or net worth of GBP 1.33 billion. The enterprise value is 912.03 million.

Market Cap	1.33B
Enterprise Value	912.03M

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.32%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	104.87M

Valuation Ratios

The trailing PE ratio is 86.76.

PE Ratio	86.76
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 105.71, with an EV/FCF ratio of 53.92.

EV / Earnings	59.69
EV / Sales	4.31
EV / EBITDA	105.71
EV / EBIT	n/a
EV / FCF	53.92

Financial Position

The company has a current ratio of 13.23, with a Debt / Equity ratio of 0.37.

Current Ratio	13.23
Quick Ratio	11.99
Debt / Equity	0.37
Debt / EBITDA	23.96
Debt / FCF	11.23
Interest Coverage	-0.91

Financial Efficiency

Return on equity (ROE) is 3.18% and return on invested capital (ROIC) is -0.43%.

Return on Equity (ROE)	3.18%
Return on Assets (ROA)	-0.38%
Return on Capital (ROIC)	-0.43%
Revenue Per Employee	476,937
Profits Per Employee	37,448
Employee Count	408
Asset Turnover	0.26
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.94% in the last 52 weeks. The beta is 1.34, so Dynavax Technologies's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-9.94%
50-Day Moving Average	12.76
200-Day Moving Average	11.64
Relative Strength Index (RSI)	48.95
Average Volume (20 Days)	704

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.24

Income Statement

In the last 12 months, Dynavax Technologies had revenue of GBP 194.59 million and earned 15.28 million in profits. Earnings per share was 0.11.

Revenue	194.59M
Gross Profit	120.82M
Operating Income	-4.61M
Pretax Income	18.07M
Net Income	15.28M
EBITDA	-1.21M
EBIT	-4.61M
Earnings Per Share (EPS)	0.11

Full Income Statement

Balance Sheet

The company has 570.01 million in cash and 189.95 million in debt, giving a net cash position of 380.06 million.

Cash & Cash Equivalents	570.01M
Total Debt	189.95M
Net Cash	380.06M
Net Cash Per Share	n/a
Equity (Book Value)	508.41M
Book Value Per Share	3.87
Working Capital	638.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.34 million and capital expenditures -3.43 million, giving a free cash flow of 16.91 million.

Operating Cash Flow	20.34M
Capital Expenditures	-3.43M
Free Cash Flow	16.91M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.09%, with operating and profit margins of -2.37% and 7.85%.

Gross Margin	62.09%
Operating Margin	-2.37%
Pretax Margin	9.29%
Profit Margin	7.85%
EBITDA Margin	-0.62%
EBIT Margin	-2.37%
FCF Margin	8.69%

Dividends & Yields

Dynavax Technologies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.32%
Shareholder Yield	1.32%
Earnings Yield	1.15%
FCF Yield	1.28%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dynavax Technologies has an Altman Z-Score of 2.54. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	n/a